Miró JM - Search Results

1

A prospective study of the risk of tuberculosis among HIV-infected patients.

Guelar A, Gatell JM, Verdejo J, Podzamczer D, Lozano L, Aznar E, Miró JM, Mallolas J, Zamora L, González J, et al. Guelar A, et al. Among authors: miro jm. AIDS. 1993 Oct;7(10):1345-9. doi: 10.1097/00002030-199310000-00007. AIDS. 1993. PMID: 8267907

2

Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy.

Pedrol E, González-Clemente JM, Gatell JM, Mallolas J, Miró JM, Graus F, Alvarez R, Mercader JM, Berenguer J, Jiménez de Anta MT, et al. Pedrol E, et al. Among authors: miro jm. AIDS. 1990 Jun;4(6):511-7. doi: 10.1097/00002030-199006000-00003. AIDS. 1990. PMID: 2386616

3

Characteristics of tuberculosis in HIV-infected patients: a case-control study.

Soriano E, Mallolas J, Gatell JM, Latorre X, Miró JM, Pecchiar M, Mensa J, Trilla A, Moreno A. Soriano E, et al. Among authors: miro jm. AIDS. 1988 Dec;2(6):429-32. doi: 10.1097/00002030-198812000-00003. AIDS. 1988. PMID: 3149490

4

Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.

Mallolas J, Zamora L, Gatell JM, Miró JM, Vernet E, Valls ME, Soriano E, SanMiguel JG. Mallolas J, et al. Among authors: miro jm. AIDS. 1993 Jan;7(1):59-64. AIDS. 1993. PMID: 8442918 Clinical Trial.

5

Viral load in asymptomatic patients with CD4+ lymphocyte counts above 500 x 10(6)/l.

García F, Vidal C, Gatell JM, Miró JM, Soriano A, Pumarola T. García F, et al. Among authors: miro jm. AIDS. 1997 Jan;11(1):53-7. doi: 10.1097/00002030-199701000-00008. AIDS. 1997. PMID: 9110075

6

Lack of evidence of a stable viral load set-point in early stage asymptomatic patients with chronic HIV-1 infection.

Vidal C, García F, Romeu J, Ruiz L, Miró JM, Cruceta A, Soriano A, Pumarola T, Clotet B, Gatell JM. Vidal C, et al. Among authors: miro jm. AIDS. 1998 Jul 30;12(11):1285-9. doi: 10.1097/00002030-199811000-00009. AIDS. 1998. PMID: 9708407

7

Withdrawal of Mycobacterium avium complex suppressive therapy in HIV-1-infected patients on highly active antiretroviral therapy.

Martínez E, Miró JM, González J, Mallolas J, Gatell JM. Martínez E, et al. Among authors: miro jm. AIDS. 1999 Jan 14;13(1):147-8. AIDS. 1999. PMID: 10207565 No abstract available.

8

A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.

García F, Romeu J, Grau I, Sambeat MA, Dalmau D, Knobel H, Gomez-Sirvent JL, Arrizabalaga J, Cruceta A, Clotet BG, Podzamczer D, Pumarola T, Gallart T, O'Brien WA, Miró JM, Gatell JM. García F, et al. Among authors: miro jm. AIDS. 1999 Dec 3;13(17):2377-88. doi: 10.1097/00002030-199912030-00009. AIDS. 1999. PMID: 10597779 Clinical Trial.

9

Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy.

Martínez E, García-Viejo MA, Marcos MA, Pérez-Cuevas JB, Blanco JL, Mallolas J, Miró JM, Gatell JM. Martínez E, et al. Among authors: miro jm. AIDS. 2000 Nov 10;14(16):2615-7. doi: 10.1097/00002030-200011100-00029. AIDS. 2000. PMID: 11101078 No abstract available.

10

Influence on survival of p24 antigen levels in patients with AIDS or advanced AIDS related complex treated with zidovudine.

Zamora L, Gatell JM, Barrera JM, Ercilla G, Gil C, Buira E, Miro JM, Soriano E. Zamora L, et al. Among authors: miro jm. Eur J Clin Microbiol Infect Dis. 1992 Dec;11(12):1181-5. doi: 10.1007/BF01961142. Eur J Clin Microbiol Infect Dis. 1992. PMID: 1291319

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

985 results

Search Page

Filters